| |
| |
|
| Insider
Information: |
Litton Mark James |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
246,586 |
|
|
Indirect Shares
|
97,689 |
|
|
| Direct
Value |
$1,929,328 |
|
|
|
Indirect Value
|
$1,472,640 |
|
|
| Total
Shares |
344,275 |
|
|
| Total
Value |
$3,401,968 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
Chief Business Officer |
2018-06-01 |
102,189 |
2018-06-01 |
78,000 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
|
2024-01-05 |
144,397 |
2024-01-05 |
19,689 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2024-01-05 |
4 |
S |
$2.91 |
$14,026 |
D/D |
(4,820) |
144,397 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
149,217 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-11-18 |
4 |
A |
$2.74 |
$1,814 |
D/D |
662 |
129,217 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-06-23 |
4 |
S |
$2.69 |
$21,412 |
D/D |
(7,960) |
128,555 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
136,515 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2022-05-18 |
4 |
A |
$7.06 |
$5,344 |
D/D |
757 |
116,515 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Executive Officer |
• • – |
2021-11-18 |
4 |
A |
$12.51 |
$11,071 |
D/D |
885 |
115,758 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2021-08-17 |
4 |
OE |
$1.35 |
$68,094 |
D/D |
50,440 |
114,873 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2021-05-18 |
4 |
A |
$14.45 |
$12,528 |
D/D |
867 |
64,433 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
19,689 |
6,563 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating Officer |
• – – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,126 |
63,566 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Chief Operating OfficerOfficer |
• – – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,440 |
|
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2018-06-01 |
4 |
AS |
$17.74 |
$405,412 |
D/D |
(22,727) |
102,189 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2018-06-01 |
4 |
OE |
$0.99 |
$22,500 |
D/D |
22,727 |
124,916 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-11-13 |
4 |
AS |
$10.80 |
$178,486 |
D/D |
(16,519) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-11-13 |
4 |
OE |
$1.65 |
$27,256 |
D/D |
16,519 |
116,451 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-10-16 |
4 |
OE |
$1.65 |
$27,258 |
D/D |
16,520 |
116,452 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-10-16 |
4 |
AS |
$12.33 |
$203,703 |
D/D |
(16,520) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-18 |
4 |
AS |
$23.10 |
$34,599 |
D/D |
(1,498) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-18 |
4 |
OE |
$1.65 |
$2,472 |
D/D |
1,498 |
101,430 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-09 |
4 |
AS |
$23.00 |
$11,500 |
D/D |
(500) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-09 |
4 |
OE |
$1.65 |
$825 |
D/D |
500 |
100,432 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-06 |
4 |
AS |
$23.02 |
$156,520 |
D/D |
(6,800) |
99,932 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-06 |
4 |
OE |
$1.27 |
$9,113 |
D/D |
6,800 |
106,732 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Business Officer |
• – – |
2017-01-05 |
4 |
AS |
$23.00 |
$50,972 |
D/D |
(2,216) |
99,932 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
